Light Mode
$5.90 ↑ +0.00 (+0.00%) Trading Up from the previous close of $5.90, $0.42 below the day’s high of $6.32
-0.76 (-11.41%) / 6M
Momentum, market sentiment, and recent alerts
TVGN reads poor: price sits below both the 20- and 200-day averages, the 12-month move is +903.2%.
No alerts for TVGN in the last day.
Earnings, valuation, and balance sheet
Company profile and competitor comparison
Tevogen, Inc. is a clinical-stage specialty immunotherapy company, which engages in the provision of off-the-shelf therapies for the treatment of infectious diseases, cancers, and neurological disorders. It focuses on its product, ExacTcell, a technology that treats acute viral infections, long-term consequences of viral infections, and viral and non-viral induced cancers. The company was founded in April 2021 and is headquartered in Warren, NJ.
No peer group available for this symbol.
Real-time scanning and AI-generated signals across the entire market.
Prices and alerts are delayed by at least 20 minutes. Chart history reflects daily closing prices. Information is provided for research purposes only and is not investment advice.